Analysts Offer Insights on Consumer Cyclical Companies: Trigano SA (OtherTGNOF) and Williams-Sonoma (WSM)
Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Trigano SA (TGNOF – Research Report) and Williams-Sonoma (WSM – Research Report).
Confident Investing Starts Here:
Trigano SA (TGNOF)
Kepler Capital analyst Alessandro Cuglietta maintained a Buy rating on Trigano SA on June 16 and set a price target of EUR178.00. The company's shares closed last Friday at $143.62.
Cuglietta has an average return of 11.3% when recommending Trigano SA.
According to TipRanks.com, Cuglietta is ranked #9309 out of 9621 analysts.
Trigano SA has an analyst consensus of Strong Buy, with a price target consensus of $194.35.
Williams-Sonoma (WSM)
Evercore ISI analyst Oliver Wintermantel maintained a Hold rating on Williams-Sonoma yesterday and set a price target of $170.00. The company's shares closed last Tuesday at $156.93.
According to TipRanks.com, Wintermantel is a 4-star analyst with an average return of 14.2% and a 71.8% success rate. Wintermantel covers the NA sector, focusing on stocks such as Petco Health and Wellness Company, Tractor Supply, and Wayfair.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Williams-Sonoma with a $181.06 average price target, which is a 15.4% upside from current levels. In a report issued on June 16, Barclays also maintained a Hold rating on the stock with a $166.00 price target.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Citi Downgrades Sherwin-Williams' (NYSE:SHW) Stock, Lowers PT
The Sherwin-Williams Company (NYSE:SHW) is one of the 10 stocks that Jim Cramer and analysts are watching. On June 13, Citi analyst Patrick Cunningham downgraded the company stock to Neutral from Buy and lowered the price target to $385 from $405 due to weak housing conditions due to high mortgage rates, and delayed Fed rate cuts. The firm is pessimistic about U.S. housing and does not see any strong signs of a rebound in the second half of the year. However, the firm showed optimism around the company's long-term growth story, but does not believe that the risk/reward is currently attractive and suggested waiting for a better time to buy Sherwin-Williams (NYSE:SHW). A close-up of a vibrant paint color being sprayed onto a wooden surface. During the episode aired on June 11, Cramer recommended another stock instead of The Sherwin-Williams Company (NYSE:SHW), as he said: 'Sherwin-Williams, okay, Dow stock now, by the way. I think Sherwin-Williams, look, I like the stock of Home Depot. Home Depot, which is, by the way, less expensive… I think some people are selling it because ICE is lining up in front of Home Depot, and I think the stock's getting hit because of that.' Sherwin-Williams (NYSE:SHW) develops, manufactures, and sells paints, coatings, and related products for a wide range of customers, including professionals and retailers. While we acknowledge the potential of SHW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
Business Insider
11 hours ago
- Business Insider
Analysts Offer Insights on Consumer Cyclical Companies: Trigano SA (OtherTGNOF) and Williams-Sonoma (WSM)
Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Trigano SA (TGNOF – Research Report) and Williams-Sonoma (WSM – Research Report). Confident Investing Starts Here: Trigano SA (TGNOF) Kepler Capital analyst Alessandro Cuglietta maintained a Buy rating on Trigano SA on June 16 and set a price target of EUR178.00. The company's shares closed last Friday at $143.62. Cuglietta has an average return of 11.3% when recommending Trigano SA. According to Cuglietta is ranked #9309 out of 9621 analysts. Trigano SA has an analyst consensus of Strong Buy, with a price target consensus of $194.35. Williams-Sonoma (WSM) Evercore ISI analyst Oliver Wintermantel maintained a Hold rating on Williams-Sonoma yesterday and set a price target of $170.00. The company's shares closed last Tuesday at $156.93. According to Wintermantel is a 4-star analyst with an average return of 14.2% and a 71.8% success rate. Wintermantel covers the NA sector, focusing on stocks such as Petco Health and Wellness Company, Tractor Supply, and Wayfair. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Williams-Sonoma with a $181.06 average price target, which is a 15.4% upside from current levels. In a report issued on June 16, Barclays also maintained a Hold rating on the stock with a $166.00 price target.
Business Insider
11 hours ago
- Business Insider
Analysts Offer Insights on Healthcare Companies: Kuros Biosciences (OtherCSBTF), CSL (OtherCMXHF) and Roche Holding AG (OtherRHHVF)
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kuros Biosciences (CSBTF – Research Report), CSL (CMXHF – Research Report) and Roche Holding AG (RHHVF – Research Report) with bullish sentiments. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Kuros Biosciences (CSBTF) Kepler Capital analyst Christophe dombu maintained a Buy rating on Kuros Biosciences on June 16 and set a price target of CHF32.50. The company's shares closed last Wednesday at $33.22, close to its 52-week high of $36.10. According to dombu is ranked #8486 out of 9621 analysts. The the analyst consensus on Kuros Biosciences is currently a Hold rating. CSL (CMXHF) Morgan Stanley analyst David Bailey maintained a Buy rating on CSL today and set a price target of A$303.00. The company's shares closed last Tuesday at $148.56. According to Bailey is a 4-star analyst with an average return of 16.4% and a 48.1% success rate. Bailey covers the Healthcare sector, focusing on stocks such as Fisher & Paykel Healthcare Corporation Limited, Ramsay Health Care, and Cochlear. CSL has an analyst consensus of Strong Buy, with a price target consensus of $203.87, implying a 37.2% upside from current levels. In a report released yesterday, Jarden also maintained a Buy rating on the stock with a A$317.61 price target. Roche Holding AG (RHHVF) Kepler Capital analyst David Evans maintained a Buy rating on Roche Holding AG on June 16 and set a price target of CHF315.00. The company's shares closed last Tuesday at $321.13. According to Evans is ranked #4919 out of 9621 analysts. The word on The Street in general, suggests a Hold analyst consensus rating for Roche Holding AG with a $352.85 average price target, implying an 8.3% upside from current levels. In a report issued on June 16, UBS also maintained a Buy rating on the stock with a CHF314.00 price target.
